Drug Trial Radar · NCT04140227
Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)
Last checked: Nov 20, 2026Latest source record: Mar 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
256
Actual
Start
Sep 24, 2020
Primary completion
Jan 5, 2022
Study completion Jan 5, 2022
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Oct 25, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objectives of this trial are to evaluate the safety and tolerability of perfluorohexyloctane (NOV03) ophthalmic solution during long-term use in subjects with Dry Eye Disease (DED) associated with MGD (Meibomian Gland Dysfunction). Further objective is to evaluate the efficacy of perfluorohexyloctane (NOV03) solution during long-term use in subjects with DED associated with MGD.
Conditions
- Dry Eye Disease (DED)
Interventions
NOV03Drug
100% Perfluorohexyloctane
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Ocular and Non-ocular Adverse EventsTime frame: 12 months
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Bausch Site 124
Birmingham, Alabama
Bausch Site 125
Scottsdale, Arizona
Bausch Site 110
Glendale, California
Bausch Site 121
Long Beach, California
Bausch Site 102
Mission Hills, California
Bausch Site 101
Newport Beach, California
Bausch Site 116
Rancho Cordova, California
Bausch Site 103
Torrance, California
Bausch Site 123
Torrance, California
Bausch Site 127
Danbury, Connecticut
Bausch Site 129
Fort Myers, Florida
Bausch Site 115
Jacksonville, Florida
Bausch Site 106
Largo, Florida
Bausch Site 117
Tampa, Florida
Bausch Site 108
Lake Villa, Illinois
Bausch Site 112
Indianapolis, Indiana
Bausch Site 119
Edgewood, Kentucky
Bausch Site 126
Winchester, Massachusetts
Bausch Site 113
Kansas City, Missouri
Bausch Site 111
St Louis, Missouri
Bausch Site 128
Slingerlands, New York
Bausch Site 114
Raleigh, North Carolina
Bausch Site 122
Cranberry Township, Pennsylvania
Bausch Site 107
Memphis, Tennessee
Bausch Site 109
Nashville, Tennessee
Bausch Site 120
El Paso, Texas
Bausch Site 104
Lakeway, Texas
Bausch Site 118
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.